Obermeyer Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Sell
8,610
-58
-0.7% -$6.7K 0.05% 112
2025
Q4
$912K Sell
8,668
-161
-2% -$15.1K 0.04% 123
2025
Q3
$741K Sell
8,829
-1,057
-11% -$87.1K 0.03% 135
2025
Q2
$783K Sell
9,886
-151,400
-94% -$12M 0.04% 124
2025
Q1
$14.5M Sell
161,286
-4,095
-2% -$382K 0.77% 40
2024
Q4
$16.5M Sell
165,381
-15,386
-9% -$1.59M 0.86% 37
2024
Q3
$20.5M Sell
180,767
-2,924
-2% -$347K 1.1% 34
2024
Q2
$22.7M Sell
183,691
-625
-0.3% -$80.5K 1.3% 29
2024
Q1
$24.3M Buy
184,316
+11,906
+7% +$1.47M 1.43% 28
2023
Q4
$18.8M Buy
172,410
+164,042
+1,960% +$17M 1.28% 30
2023
Q3
$861K Sell
8,368
-325
-4% -$35K 0.06% 74
2023
Q2
$1M Hold
8,693
0.07% 69
2023
Q1
$925K Sell
8,693
-8,076
-48% -$872K 0.07% 72
2022
Q4
$1.86M Sell
16,769
-152
-0.9% -$15.5K 0.14% 54
2022
Q3
$1.46M Buy
16,921
+7,286
+76% +$650K 0.12% 57
2022
Q2
$878K Buy
9,635
+198
+2% +$17.6K 0.06% 74
2022
Q1
$774K Buy
9,437
+756
+9% +$59.6K 0.05% 95
2021
Q4
$665K Sell
8,681
-239
-3% -$19K 0.04% 104
2021
Q3
$670K Sell
8,920
-336
-4% -$25.6K 0.04% 101
2021
Q2
$720K Sell
9,256
-877
-9% -$65.2K 0.04% 103
2021
Q1
$745K Buy
10,133
+2,152
+27% +$159K 0.05% 98
2020
Q4
$623K Sell
7,981
-419
-5% -$32K 0.04% 76
2020
Q3
$665K Buy
8,400
+884
+12% +$69.2K 0.05% 69
2020
Q2
$555K Sell
7,516
-7
-0.1% -$527 0.05% 72
2020
Q1
$552K Sell
7,523
-1,001
-12% -$78.7K 0.06% 60
2019
Q4
$740K Buy
8,524
+284
+3% +$23.3K 0.07% 62
2019
Q3
$662K Buy
8,240
+722
+10% +$57.9K 0.06% 62
2019
Q2
$602K Buy
7,518
+104
+1% +$7.96K 0.05% 72
2019
Q1
$588K Sell
7,414
-541
-7% -$40.5K 0.06% 70
2018
Q4
$580K Buy
7,955
+70
+0.9% +$4.94K 0.06% 66
2018
Q3
$534K Buy
7,885
+1,048
+15% +$66.8K 0.05% 73
2018
Q2
$396K Hold
6,837
0.04% 82
2018
Q1
$355K Sell
6,837
-419
-6% -$22.6K 0.03% 84
2017
Q4
$390K Buy
7,256
+357
+5% +$19.8K 0.03% 90
2017
Q3
$422K Buy
6,899
+1,618
+31% +$98.1K 0.04% 84
2017
Q2
$323K Buy
5,281
+131
+3% +$7.97K 0.03% 92
2017
Q1
$312K Sell
5,150
-1,572
-23% -$95.4K 0.03% 100
2016
Q4
$378K Hold
6,722
0.04% 94
2016
Q3
$400K Sell
6,722
-87
-1% -$5.09K 0.04% 86
2016
Q2
$374K Buy
6,809
+419
+7% +$22.3K 0.04% 88
2016
Q1
$323K Hold
6,390
0.03% 97
2015
Q4
$322K Sell
6,390
-1,714
-21% -$86.4K 0.03% 95
2015
Q3
$382K Hold
8,104
0.04% 82
2015
Q2
$440K Buy
8,104
+1,048
+15% +$58.8K 0.04% 88
2015
Q1
$387K Hold
7,056
0.03% 100
2014
Q4
$382K Buy
+7,056
New +$393K 0.03% 106
2013
Q3
Sell
-314
Closed -$14K 194
2013
Q2
$14K Buy
+314
New +$14K ﹤0.01% 237

Other funds holding MRK

Obermeyer Wealth Partners's MRK Position: Q1 2026 in Review

Obermeyer Wealth Partners reduced its Merck (MRK) stake by 0.67% in Q1 2026, selling an estimated $6.7K and leaving 8,610 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #112.

Obermeyer Wealth Partners first reported a position in MRK in Q2 2013 and has held it in 47 quarters since. The position peaked at $24.3M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Obermeyer Wealth Partners held 8,610 shares of Merck worth $1.04M as of Q1 2026.
  • Obermeyer Wealth Partners sold 58 Merck shares in Q1 2026, an estimated $6.7K.
  • Merck made up 0.05% of Obermeyer Wealth Partners's portfolio in Q1 2026, its #112 holding.
  • Obermeyer Wealth Partners first reported a position in Merck in Q2 2013 and has held it in 47 quarters since.
  • Obermeyer Wealth Partners's Merck position peaked at $24.3M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2026, filed 21 Apr 2026.